SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

IDEX

IDEX is trending as the community anticipates potential news regarding a migration plan and increased volume, with many traders optimistic about a breakout as it recovers from recent volatility. Speculation remains high among holders who are comparing its setup to previous market runs while debating whether current price action signals a sustained rally or a temporary shift.

NKN is building the largest blockchain for network sharing.

New Kind of Network

NKN is capturing significant attention as traders speculate on potential partnerships and market reversals, with many members of the community comparing its current movement to other recent low-cap surges. Discussions are heavily focused on the stock's potential for a short squeeze and long-term recovery, though some participants remain skeptical, labeling the volatility as manipulated.

Bitcoin is the world's first decentralized cryptocurrency, created in 2009 by the pseudonymous Satoshi Nakamoto. It enables peer-to-peer electronic cash transactions without intermediaries like banks or governments, operating on a blockchain secured by Proof of Work mining and the SHA-256 cryptographic algorithm.   With a fixed supply cap of 21 million coins and programmatic halvings every four years that reduce miner rewards, Bitcoin is designed as a deflationary digital asset often called "digital gold." Its value stems from solving the double-spending problem without trusted intermediaries, creating the first truly scarce digital asset with censorship resistance and permissionless access that no government, corporation, or individual can control.  Bitcoin operates as a decentralized peer-to-peer network where transactions are recorded on a public ledger called the blockchain, distributed across thousands of computers globally. Transactions are grouped into blocks added approximately every 10 minutes through mining, where specialized computers compete to solve complex mathematical puzzles.   Bitcoin has achieved mainstream adoption through multiple vectors. The January 2024 SEC approval of 11 spot Bitcoin ETFs opened Bitcoin investment to traditional finance participants, and corporations like Strategy (formerly MicroStrategy) are using Bitcoin as a treasury reserve asset to protect against currency debasement, offering MSTR holders amplified exposure to Bitcoin.   The Bitcoin ecosystem continues to evolve with innovations like Ordinals, which emerged in January 2023 to enable NFT-like functionality directly on Bitcoin, and BRC-20 tokens, an experimental standard for creating fungible tokens using Ordinal inscriptions. BTCFi (Bitcoin Finance) represents emerging financial applications extending beyond Bitcoin's traditional role, with protocols like Babylon allowing Bitcoin holders to stake BTC to secure Proof of Stake chains.

Bitcoin

Bitcoin is currently experiencing intense market volatility and choppy price action as traders react to the stalemate in high-stakes negotiations between the U.S. and Iran regarding transit through the Strait of Hormuz. While some in the community focus on technical levels and institutional accumulation, sentiment is sharply divided, with many actively discussing the potential for a larger correction if geopolitical tensions escalate further.

Paramount Skydance Corp. is a next-generation global media and entertainment company that engages in providing content creation and distribution services. It operates through the following business segments: Studios, Direct-to-Consumer, and TV Media. Its portfolio unites brands including Paramount Pictures, Paramount Television, CBS, CBS News, Nickelodeon, MTV, BET, Comedy Central, Showtime, Paramount Plus, Pluto TV, and Skydance’s Animation, Film, Television, Interactive/Games, and Sports divisions. The company was founded on June 3, 2024 and is headquartered in New York, NY.

Paramount Skydance Corp. - Ordinary Shares - Class B

Paramount Skydance is generating significant investor buzz as the company secures $24 billion in funding from Middle East sovereign wealth funds, fueling optimism about its ability to deleverage and finalize the Warner Bros. Discovery merger. Community discourse is heavily focused on the potential for a short squeeze given the high short interest, alongside active debates regarding the strategic value of newly issued warrants and the company's long-term pivot toward an AI-driven, tech-forward media model.

Coherent Corp. engages in the development, refinement, manufacturing, and marketing of engineered materials, opto-electronic components and devices, and lasers for use in the industrial, communications, electronics, and instrumentation markets. It operates through the following segments: Networking, Materials, and Lasers. The Networking segment leverages compound semiconductor technology platforms and deep knowledge of end-user applications. The Materials segment markets engineered materials and optoelectronic devices. The Lasers segment serves industrial customers in semiconductor capital equipment, display capital equipment, precision manufacturing, and aerospace and defense, as well as instrumentation customers in life sciences and scientific research. The company was founded by Carl J. Johnson in 1971 and is headquartered in Saxonburg, PA.

Coherent Corp

Coherent Corp is trending as investors aggressively position in the photonics and optical infrastructure space, driven by multibillion-dollar strategic investments from Nvidia and persistent demand for high-speed data center connectivity. The community is actively debating the transition from copper to optical solutions, with Coherent widely regarded as a foundational 'picks and shovels' play alongside industry peers to support the massive data transfer requirements of scaling AI compute clusters.

Assertio Holdings, Inc. is a commercial pharmaceutical company, which engages in acquisitions, licensing, and mergers. The firm focuses on portfolio of neurology, inflammation, and pain medications. Its products include INDOCIN, Sympazan, Otrexup, SPRIX, CAMBIA, and Zipsor. The company was founded on August 7, 1995 and is headquartered in Lake Forest, IL.

Assertio Holdings Inc

Assertio Holdings is currently under significant investor scrutiny as shareholders debate the merits of a potential cash tender offer from Garda Therapeutics, with many expressing frustration over the valuation relative to the company's cash reserves and core assets like Rolvedon. The community is actively discussing possible regulatory and legal avenues to oppose the deal, while concerns persist regarding management's transparency and potential conflicts of interest surrounding executive compensation and the timing of the acquisition.

Upstart Holdings, Inc. engages in the provision of a cloud-based artificial intelligence lending platform. It operates through the following segments: Personal Lending, Auto Lending, and Other. The Personal Lending segment focuses on unsecured personal loans and small dollar loans. The Auto Lending segment is involved in auto refinance and auto retail loans. The Other segment refers to HELOCs and other. The company was founded by David Joseph Girouard, Anna Mongayt Counselman, and Paul Gu in December 2013 and is headquartered in San Mateo, CA.

Upstart Holdings Inc

Upstart is experiencing intense bearish pressure and volatility as investors react to the company's strategic move to seek a national bank charter while navigating a difficult macro environment. The community remains deeply divided, with many traders frustrated by persistent short selling and underperformance relative to peers, while others view current price levels as an oversold opportunity for long-term recovery.

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Aventura, FL.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantir is currently driving market conversation as investors weigh a presidential endorsement and significant government contract activity against intense short-selling pressure from institutional traders. While the community remains deeply divided over the company's valuation and the long-term competitive threat from Anthropic, active discussion is focused on the stock's potential for a violent reversal driven by political tailwinds and massive institutional volume.

Ondas, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in West Palm Beach, FL.

Ondas Inc.

Ondas Inc

Ondas Inc. is seeing intense investor focus fueled by a surge in defense-related contracts, including security deployments for the 2026 FIFA World Cup and major demining programs, alongside broader tailwinds in the drone and autonomous systems sector. While the community is actively debating the impact of a proposed increase in authorized shares and persistent volatility, bullish sentiment remains centered on the company's aggressive M&A strategy and its positioning within a growing defense-tech infrastructure.

Bankr is an advanced AI agent focused on simplifying the process of buying and selling digital assets. Bankr was the first AI agent on Farcaster to help you quickly buy all your favorites coins directly in the social. BankrCoin is the official coin of the agent and was deployed by Bankr itself directly in the Farcaster social feed. Fees from swaps go to support BankrCoin. Bankr is available on Farcaster and will soon be launching a private terminal, token recs, and limit orders on Base.

BankrCoin

BankrCoin is currently trending due to its emerging role as a key infrastructure layer for on-chain AI agents within the Base ecosystem. While the community remains sharply divided between short-term traders looking to scalp volatility and long-term believers highlighting the project's real revenue generation and ongoing developer updates, sentiment is heavily influenced by the potential for a major market cap revaluation.

statis crypto Watchlist

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Collegium Pharmaceutical (NASDAQ:COLL) Stock Price Crosses Below Fifty Day Moving Average   - Should You Sell?

Collegium Pharmaceutical (NASDAQ:COLL) Stock Crosses Below Fifty Day Moving Average - Here's Why...

JPMorgan Chase & Co. Acquires 139,689 Shares of Collegium Pharmaceutical, Inc. $COLL

JPMorgan Chase & Co. boosted its holdings in shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL - Free Report) by 193.8% in the third quarter, according to the company in its most recent 13F...

Wedge Capital Management L L P NC Acquires New Stake in Collegium Pharmaceutical, Inc. $COLL

Wedge Capital Management L L P NC acquired a new stake in shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL - Free Report) in the fourth quarter, according to the company in its most recent...

Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Receives Consensus Recommendation of "Moderate Buy" from Analysts

Collegium Pharmaceutical, Inc. (NASDAQ:COLL - Get Free Report) has been assigned a consensus recommendation of "Moderate Buy" from the seven brokerages that are covering the firm, MarketBeat Ratings...

Collegium Pharmaceutical, Inc. $COLL Shares Bought by Assenagon Asset Management S.A.

Assenagon Asset Management S.A. lifted its position in shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL - Free Report) by 161.6% in the 4th quarter, according to its most recent disclosure with...

Collegium Pharmaceutical EVP Sells Nearly 50,000 Shares Worth $2 Million

Key PointsScott Dreyer sold 49,976 shares on March 3, 2026, for approximately $2.02 million at a weighted average price of about $40.41 per share...

Collegium Pharmaceutical (NASDAQ:COLL) EVP Sells 13,976 Shares

Collegium Pharmaceutical, Inc. (NASDAQ:COLL - Get Free Report) EVP David Dieter sold 13,976 shares of the stock in a transaction on Wednesday, March 18th. The stock was sold at an average price of $34.92, for a total value of $488,041.92. Following the completion of the transaction, the executive...

Insider Selling: Collegium Pharmaceutical (NASDAQ:COLL) EVP Sells 13,976 Shares of Stock

Collegium Pharmaceutical, Inc. (NASDAQ:COLL - Get Free Report) EVP David Dieter sold 13,976 shares of the firm's stock in a transaction dated Wednesday, March 18th. The shares were sold at an average...

Collegium Pharmaceutical (NASDAQ:COLL) Given Buy Rating at HC Wainwright

HC Wainwright reissued a "buy" rating and set a $60.00 target price on shares of Collegium Pharmaceutical in a research report on Friday...

Needham & Company LLC Reiterates Buy Rating for Collegium Pharmaceutical (NASDAQ:COLL)

Needham & Company LLC reaffirmed a "buy" rating and set a $56.00 target price (up from $54.00) on shares of Collegium Pharmaceutical in a report on Thursday...

Collegium Pharmaceutical, Inc. is a pharmaceutical company, which engages in development and planning to commercialize next generation, abuse-deterrent products for the treatment of patients suffering from chronic pain and other diseases. Its products include Xtampza ER, Nucynta ER and Nucynta IR, Belbuca, and Symproic. The company was founded by Michael Thomas Heffernan in April 2002 and is headquartered in Stoughton, MA.

COLL
Collegium Pharmaceutical Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest COLL News

COLLCollegium Pharmaceutical Inc